Category: Press Releases
Dr. David Sinclair Assumes Presidency of the AHLR
June 15, 2023
New York, June 14th, 2023 – The Academy for Health and Lifespan Research (AHLR) is proud to announce the election of Dr. David Sinclair as its new President. Dr. Sinclair,
The SynBioBeta Conference is Almost Here
May 10, 2023
At Oakland Marriott, California May 23-25, the SynBioBeta Global Synthetic Biology Conference is happening. This is a three-day event featuring industry thought leaders speaking sessions, exhibitors with hands-on product
Life Biosciences Claims Visual Restoration in Primates
April 26, 2023
Life Biosciences, a company co-founded by the well-known Dr. David Sinclair, has recently claimed that it has reversed a form of neuropathy in nonhuman primates through gene therapy and epigenetic
The Maximon Longevity Prize 2023: 50,000 CHF (56,000 USD)
April 20, 2023
Maximon, Europe’s first longevity company builder, is pleased to announce that applications for the Maximon Longevity Prize 2023 are now open. This prestigious prize is awarded to translational longevity research
Cardio Diagnostics Announces Strategic Engagement With Us
April 12, 2023
Cardio Diagnostics Holdings, Inc (Nasdaq: CDIO), an artificial intelligence-powered precision cardiovascular medicine company, today announced a strategic engagement with Lifespan.io, a leading nonprofit advocacy foundation and online platform focusing on the extension
Announcing the Formation of the Longevity Science Caucus
February 21, 2023
The Alliance for Longevity Initiatives (A4LI) would like to applaud the efforts of Congressman Gus Bilirakis (R-FL) and Congressman Paul Tonko (D-NY) for co-chairing and launching the newly formed bipartisan
Kizoo Portfolio Company Cellvie Closes $5.5M of Funding
February 8, 2023
The company cellvie, part of the portfolio of biotechnology holding company Kizoo Technology Capital, recently received $5.5 million to develop a mitochondria-based therapy. The full press release is included here.
Longevity Investors Lunch at Davos
January 24, 2023
A Longevity Investors Lunch hosted by Maximon, Longevity Investors Conference, and Biolytica has been hosted at a satellite event of the well-known Davos conference. The press release is included here.
Open Longevity Foundation Announces Open Genes Database
January 24, 2023
Open Longevity Foundation has announced Open Genes, a database of longevity-associated genes and a tool for future anti-aging therapy development. The full press release is included here. Open Longevity Foundation
Gero Enters Research Collaboration with Pfizer
January 10, 2023
Gero today announced that it has entered into a research collaboration with Pfizer to apply Gero’s machine learning technology platform to discover potential therapeutic targets for fibrotic diseases using large-scale
Immunis Begins Clinical Trial of Stem Cell Secretome
January 5, 2023
Intending to treat sarcopenia, the private biotechnology company Immunis has begun a human clinical trial of a stem cell secretome product that affects the immune system. The company’s full press
Turn Biotechnologies Changes Paradigm in Skin Rejuvenation
December 6, 2022
Turn Biotechnologies has unveiled data at four industry conferences suggesting that a single ERA treatment may be more effective than combination therapies used today. Biomarker analysis demonstrates ERA’s regenerative impact
BioAge Announces Positive Results Against Muscle Atrophy
December 5, 2022
BioAge Labs has concluded a Phase 1b study in which human volunteers undergoing 10 days of bed rest were shown to have their related muscle atrophy significantly attenuated by BGE-105.
Longevity Biotech Fellowship Announces Launch
November 21, 2022
On Deck Longevity Biotech and the founders of LessDeath.org have collaborated to start the Longevity Biotech Fellowship, a new initiative focusing on bringing upcoming professionals into the longevity industry. The
The Quantum Healthy Longevity Innovation Mission Launches
November 14, 2022
London. 14 November 2022. The National Innovation Centre for Ageing and Collider Health launch the Quantum Healthy Longevity Innovation Mission with a keynote by Lord Bethell, former Parliamentary Under Secretary
Dr. David Sinclair Assumes Presidency of the AHLR
June 15, 2023
New York, June 14th, 2023 – The Academy for Health and Lifespan Research (AHLR) is proud to announce the election of Dr. David Sinclair as its new President. Dr. Sinclair, a distinguished Professor of Genetics at Harvard Medical School and renowned author of the New York
The SynBioBeta Conference is Almost Here
May 10, 2023
At Oakland Marriott, California May 23-25, the SynBioBeta Global Synthetic Biology Conference is happening. This is a three-day event featuring industry thought leaders speaking sessions, exhibitors with hands-on product demos, and focused industry networking opportunities. Global entrepreneurs, academics, investors, and policymakers attend SynBioBeta to connect,
Life Biosciences Claims Visual Restoration in Primates
April 26, 2023
Life Biosciences, a company co-founded by the well-known Dr. David Sinclair, has recently claimed that it has reversed a form of neuropathy in nonhuman primates through gene therapy and epigenetic reprogramming. The full press release is included here. Life Biosciences, a biotechnology company advancing innovative cellular
The Maximon Longevity Prize 2023: 50,000 CHF (56,000 USD)
April 20, 2023
Maximon, Europe’s first longevity company builder, is pleased to announce that applications for the Maximon Longevity Prize 2023 are now open. This prestigious prize is awarded to translational longevity research projects that demonstrate exceptional potential to extend human healthspan and lifespan. Maximon rewards the three winners
Cardio Diagnostics Announces Strategic Engagement With Us
April 12, 2023
Cardio Diagnostics Holdings, Inc (Nasdaq: CDIO), an artificial intelligence-powered precision cardiovascular medicine company, today announced a strategic engagement with Lifespan.io, a leading nonprofit advocacy foundation and online platform focusing on the extension of healthy human lifespan through research and education. This engagement seeks to enhance public awareness and
Announcing the Formation of the Longevity Science Caucus
February 21, 2023
The Alliance for Longevity Initiatives (A4LI) would like to applaud the efforts of Congressman Gus Bilirakis (R-FL) and Congressman Paul Tonko (D-NY) for co-chairing and launching the newly formed bipartisan Congressional Caucus for Longevity Science. The “Longevity Science Caucus” aims to increase funding for aging and
Kizoo Portfolio Company Cellvie Closes $5.5M of Funding
February 8, 2023
The company cellvie, part of the portfolio of biotechnology holding company Kizoo Technology Capital, recently received $5.5 million to develop a mitochondria-based therapy. The full press release is included here. cellvie Inc., a leader in Therapeutic Mitochondria Transplantation (TMT), an approach developed at Harvard Medical School, closes a
Longevity Investors Lunch at Davos
January 24, 2023
A Longevity Investors Lunch hosted by Maximon, Longevity Investors Conference, and Biolytica has been hosted at a satellite event of the well-known Davos conference. The press release is included here. Longevity stays in the limelight on the streets of Davos for the second time during this
Open Longevity Foundation Announces Open Genes Database
January 24, 2023
Open Longevity Foundation has announced Open Genes, a database of longevity-associated genes and a tool for future anti-aging therapy development. The full press release is included here. Open Longevity Foundation released a novel database of genes involved in human aging and longevity — Open Genes. It
Gero Enters Research Collaboration with Pfizer
January 10, 2023
Gero today announced that it has entered into a research collaboration with Pfizer to apply Gero’s machine learning technology platform to discover potential therapeutic targets for fibrotic diseases using large-scale human-based data. As part of this research collaboration, the companies will leverage Pfizer’s expertise and Gero’s
Immunis Begins Clinical Trial of Stem Cell Secretome
January 5, 2023
Intending to treat sarcopenia, the private biotechnology company Immunis has begun a human clinical trial of a stem cell secretome product that affects the immune system. The company’s full press release is included here. Immunis, Inc., a private biotech company developing an innovative treatment for age
Turn Biotechnologies Changes Paradigm in Skin Rejuvenation
December 6, 2022
Turn Biotechnologies has unveiled data at four industry conferences suggesting that a single ERA treatment may be more effective than combination therapies used today. Biomarker analysis demonstrates ERA’s regenerative impact on fibroblast proliferation, collagen VII production, and the eTurna™ lipid-based delivery platform proves groundbreakingly effective at
BioAge Announces Positive Results Against Muscle Atrophy
December 5, 2022
BioAge Labs has concluded a Phase 1b study in which human volunteers undergoing 10 days of bed rest were shown to have their related muscle atrophy significantly attenuated by BGE-105. RICHMOND, Calif.–(BUSINESS WIRE)–BioAge Labs, Inc. (“BioAge”), a clinical-stage biotechnology company developing therapeutics that target the molecular
Longevity Biotech Fellowship Announces Launch
November 21, 2022
On Deck Longevity Biotech and the founders of LessDeath.org have collaborated to start the Longevity Biotech Fellowship, a new initiative focusing on bringing upcoming professionals into the longevity industry. The full press release is included below. Would you like to help accelerate the biggest revolution in
The Quantum Healthy Longevity Innovation Mission Launches
November 14, 2022
London. 14 November 2022. The National Innovation Centre for Ageing and Collider Health launch the Quantum Healthy Longevity Innovation Mission with a keynote by Lord Bethell, former Parliamentary Under Secretary of State for Technology, Innovation and Life Sciences, to shift ‘sickcare’ to a new model based